United Therapeutics
UTHR
UTHR
390 hedge funds and large institutions have $7.26B invested in United Therapeutics in 2021 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 114 increasing their positions, 151 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more call options, than puts
Call options by funds: $78.3M | Put options by funds: $72.1M
0.77% more ownership
Funds ownership: 96.81% → 97.58% (+0.77%)
25% less repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 151
Holders
390
Holding in Top 10
16
Calls
$78.3M
Puts
$72.1M
Top Buyers
1 | +$86.3M | |
2 | +$72.2M | |
3 | +$69.1M | |
4 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$33.9M |
5 |
BC
Brahman Capital
New York
|
+$33.8M |
Top Sellers
1 | -$69M | |
2 | -$66.9M | |
3 | -$66.9M | |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$52.1M |
5 |
First Trust Advisors
Wheaton,
Illinois
|
-$35.8M |